The global narcotics scanner market is rapidly evolving due to technological advancements in the development of portable medical devices that can detect the presence of illicit drugs. Narcotics scanners employ spectroscopic techniques like Raman spectroscopy and infrared spectroscopy to identify and characterize the molecular structure of various narcotics including cocaine, heroin, methamphetamines and other synthetic drugs. These devices provide non-invasive, portable and easy-to-use detection solutions for law enforcement agencies at airports, border checkpoints and other public places to curb drug smuggling activities.

The global narcotics scanner market is estimated to be valued at US$ 2,735.68 billion in 2024 and is expected to exhibit a CAGR of 7.9% over the forecast period 2024-2031, as highlighted in a new report published by Coherent Market Insights.

Market Key Trends:

One of the major trends driving the growth of the narcotics scanner market is the evolution of novel spectroscopic techniques that enable rapid, accurate and simultaneous detection of multiple illicit substances. Vendors are focusing on integrating technologies like Fourier transform infrared spectroscopy (FTIR), Raman spectroscopy, nuclear magnetic resonance (NMR) spectroscopy and ion mobility spectrometry (IMS) into portable, handheld narcotics scanners. This allows for advanced detection capabilities without bulkier laboratory equipment requirements. The miniaturization of scanning devices supported by cloud-based AI platforms is also transforming narcotics detection by enabling real-time data analysis, automatic identification of unknown substances and remote scanning capabilities.

Porter’s Analysis

Threat of new entrants: The threat of new entrants is moderate in the narcotics scanner market due to the requirement of high R&D investment and regulatory approvals.

Bargaining power of buyers: The bargaining power of buyers is high in the narcotics scanner market as there are multiple manufacturers offering similar products.

Bargaining power of suppliers: The bargaining power of suppliers is moderate due to the presence of multiple component suppliers in the market.

Threat of new substitutes: There is low threat of substitution in the narcotics scanner market as narcotics scanners have limited substitutes for drug detection and identification.

Competitive rivalry: The competitive rivalry in the narcotics scanner market is high due to the presence of multiple domestic and international players competing on technological innovation, product differentiation, and pricing.

Key Takeaways

The global Narcotics Scanner Market Share is expected to witness high growth. The global narcotics scanner market is estimated to be valued at US$ 2,735.68 billion in 2024 and is expected to exhibit a CAGR of 7.9% over the forecast period 2024-2031.

Regional analysis:

North America is projected to hold the largest share of the narcotics scanner market during the forecast period due to stringent laws for drug control and a high number of drug detection drives conducted by enforcement authorities in this region. Furthermore, the increasing investments by various government associations for advanced drug detection technologies will boost the market growth.

Key players:

Key players operating in the narcotics scanner market are Akers Biosciences, Inc., Philips Healthcare, Abbott Laboratories, GE Healthcare, Nemaura Medical, Inc., Integrity Applications Inc., OrSense, MediWise Ltd., and Medtronic Plc. Akers Biosciences, Inc. offers a handheld narcotics identification system called TriCorder, which helps identify opiates using infrared spectroscopy.

*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it